Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.11851/3374
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBalcı, Melih-
dc.contributor.authorAtan, Ali-
dc.contributor.authorŞenel, Çağdaş-
dc.contributor.authorGüzel, Özer-
dc.contributor.authorAslan, Yılmaz-
dc.contributor.authorLokman, Utku-
dc.contributor.authorKayalı, Mustafa-
dc.contributor.authorBilgin, Övunç-
dc.date.accessioned2020-02-13T07:08:08Z-
dc.date.available2020-02-13T07:08:08Z-
dc.date.issued2019
dc.identifier.citationBalci, M., Atan, A., Senel, C., Guzel, O., Aslan, Y., Lokman, U., ... & Bilgin, O. (2019). Comparison of the treatment efficacies of paroxetine, fluoxetine and dapoxetine in low socioeconomic status patients with lifelong premature ejaculation. Central European Journal of Urology, 72(2), 185.en_US
dc.identifier.issn2080-4806
dc.identifier.urihttps://hdl.handle.net/20.500.11851/3374-
dc.identifier.urihttp://ceju.online/journal/2019/premature-ejaculation-paroxetine-fluoxetine-dapoxetine-1855.php-
dc.description.abstractIntroduction To assess the treatment efficacies of paroxetine, fluoxetine and dapoxetine in patients with lifelong premature ejaculation (PE). Material and methods One hundred and seventy male patients with lifelong PE were included in our study. Premature ejaculation profile (PEP) and Intravaginal ejaculation latency times (IELT) were recorded. Paroxetine 20 mg/d was given in Group 1 (n = 64), fluoxetine 20 mg/d was given in Group 2 (n = 47) and dapoxetine 30 mg on demand (at least two times/week) was given in Group 3 (n = 59) patients. After 1 month of treatment, the patients' IELT, PEP and patient reported clinical global impression of change (CGIC) were completed. Results The mean age was 36 +/- 9.2 years. There was no difference between the groups' age, PEP and IELT before treatment (p >0.05). PEP and IELT improved in all three groups (p <0.001). The changes in the 1st and 3rd questions of PEP was significantly higher in group 1 than in the other groups (pPEP-1 = 0.042, pPEP-3 = 0.001). The changes in the 2nd and 4th questions of PEP were similar between groups (pPEP-2 = 0.444, pPEP-4 = 0.442). In group 1 and 3 IELT changes were better than group 2 (pIIEL1-3 = 0.297, pIIEL1-2 = 0.017, pIIEL2-3 = 0.100). There was no difference between CGIC scores (p = 0.087). The treatment was terminated by 8 patients in Group 1 and 9 patients in Group 2 because of side effects. Conclusions While paroxetine treatment seemed to be better than the other medications, dapoxetine 30 mg treatment has less side effects than the two others and its' on demand usage makes it more prominent than the others.en_US
dc.language.isoenen_US
dc.publisherPolish Urological Associationen_US
dc.relation.ispartofCentral European Journal of Urologyen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectFluoxetineen_US
dc.subjectpremature ejaculationen_US
dc.subjectparoxetineen_US
dc.subjectdapoxetineen_US
dc.titleComparison of the treatment efficacies of paroxetine, fluoxetine and dapoxetine in low socioeconomic status patients with lifelong premature ejaculationen_US
dc.typeArticleen_US
dc.departmentFaculties, School of Medicine, Department of Surgical Sciencesen_US
dc.departmentFakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümütr_TR
dc.identifier.volume72
dc.identifier.issue2
dc.identifier.startpage185
dc.identifier.endpage190
dc.authorid0000-0003-0772-3319-
dc.identifier.wosWOS:000505933500015en_US
dc.identifier.scopus2-s2.0-85070776122en_US
dc.institutionauthorLokman, Utku-
dc.identifier.pmid31482028en_US
dc.identifier.doi10.5173/ceju.2019.1855-
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.scopusqualityQ3-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairetypeArticle-
item.cerifentitytypePublications-
item.languageiso639-1en-
crisitem.author.dept03.35. Department of Urology-
Appears in Collections:Cerrahi Tıp Bilimleri Bölümü / Department of Surgical Sciences
PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

2
checked on Mar 23, 2024

WEB OF SCIENCETM
Citations

3
checked on Mar 23, 2024

Page view(s)

36
checked on Mar 25, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.